Replies to post #48122 on DNAprint Genomics (DNAG)

[cloud477]

Hello frog
Continuing our discussion...

I had made the remark, "But it has not been made until now.", and frog correctly pointed out that super EPO had been previously created by the patent owners. My statement should be amended to "But it has not been made in a production capacity and formally tested until now."

As for the question of the drug being returned by an unknown entity....it's still a question with little merit. We don't even know that the drug was ever placed with another company. There is precious little "proof" and after looking at the scientific evidence of the dimer compared with the monomer, I would absolutely need some kind of reasonable evidence to even consider a previous placement.
It's possible, but without any substantial evidence, there seems to be no reason at all to accept this premise as fact or even theory, and I see no reason to try and assign the value of this dimer based on a lack of evidence.


You said,
"Since the vast majority of drugs that enter the development process fail to complete said process, ( believe the success rate is in single digits), then perhaps the cacaphony will begin when the drug has successfully completed the ordeal. That would be approximately 'a few hundred million' dollars from now."

Frog, you know as well as I do that a drug does not need to "complete the ordeal" to gain pps. Heck, I'd be happy with a succesful phase 1.

So would you.

best of luck

jack